Source: Investing.com ↗

H.C. Wainwright reiterates Janux Therapeutics stock rating at buy

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

BTC/USDT

$65,541.42

-4.29%

USDC/USDT

$1.00

-0.01%

ETH/USDT

$1,832.88

-4.60%

SOL/USDT

$73.14

-7.98%

USD1/USDT

$0.9990

-0.01%